Proton MR spectroscopy of HIV-infected patients

Characterization of abnormalities with imaging and clinical correlation

Jeffrey G. Jarvik, Robert E. Lenkinski, Robert I. Grossman, John M. Gomori, Mitchell D. Schnall, Ian Frank

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

The purpose of this study was to characterize the proton magnetic resonance (MR) spectroscopic findings in the brains of patients infected with human immunodeficiency virus (HIV). Peak areas were used to calculate metabolite ratios. Spectra were analyzed by blinded readers who calculated areas under metabolite peaks. MR images were evaluated by blinded readers, with both white and gray matter being rated as normal or abnormal. An aggregate index that combined N-acerylaspartate/creatine (Cr), choline/Cr, and marker peak/Cr ratios resulted in mean scores for patients and control subjects of 4.4 ± 1.5 (standard deviation [SD]) and 2.5 ± 0.4, respectively (P = .001). Eight of 11 patients (73%) had abnormal MR images versus four of 11 control subjects. Thirteen of 15 patient spectra (87%) were abnormal (>2 SDs from the mean of the control subjects), while only one of 10 control spectra was abnormal. These initial results indicate that proton MR spectroscopy is a potentially useful modality for detecting HIV involvement in the central nervous system.

Original languageEnglish (US)
Pages (from-to)739-744
Number of pages6
JournalRadiology
Volume186
Issue number3
StatePublished - Mar 1993

Fingerprint

Creatine
HIV
Magnetic Resonance Spectroscopy
Choline
Protons
Central Nervous System
Proton Magnetic Resonance Spectroscopy
Brain

Keywords

  • Acquired immunodeficiency syndrome (AIDS), 10.2068
  • Brain, infection, 10.2068
  • Brain, MR, 10.1214
  • Magnetic resonance (MR), spectroscopy, 10.12145

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Jarvik, J. G., Lenkinski, R. E., Grossman, R. I., Gomori, J. M., Schnall, M. D., & Frank, I. (1993). Proton MR spectroscopy of HIV-infected patients: Characterization of abnormalities with imaging and clinical correlation. Radiology, 186(3), 739-744.

Proton MR spectroscopy of HIV-infected patients : Characterization of abnormalities with imaging and clinical correlation. / Jarvik, Jeffrey G.; Lenkinski, Robert E.; Grossman, Robert I.; Gomori, John M.; Schnall, Mitchell D.; Frank, Ian.

In: Radiology, Vol. 186, No. 3, 03.1993, p. 739-744.

Research output: Contribution to journalArticle

Jarvik, JG, Lenkinski, RE, Grossman, RI, Gomori, JM, Schnall, MD & Frank, I 1993, 'Proton MR spectroscopy of HIV-infected patients: Characterization of abnormalities with imaging and clinical correlation', Radiology, vol. 186, no. 3, pp. 739-744.
Jarvik, Jeffrey G. ; Lenkinski, Robert E. ; Grossman, Robert I. ; Gomori, John M. ; Schnall, Mitchell D. ; Frank, Ian. / Proton MR spectroscopy of HIV-infected patients : Characterization of abnormalities with imaging and clinical correlation. In: Radiology. 1993 ; Vol. 186, No. 3. pp. 739-744.
@article{66fa037abd0b472dbb26e20480db7460,
title = "Proton MR spectroscopy of HIV-infected patients: Characterization of abnormalities with imaging and clinical correlation",
abstract = "The purpose of this study was to characterize the proton magnetic resonance (MR) spectroscopic findings in the brains of patients infected with human immunodeficiency virus (HIV). Peak areas were used to calculate metabolite ratios. Spectra were analyzed by blinded readers who calculated areas under metabolite peaks. MR images were evaluated by blinded readers, with both white and gray matter being rated as normal or abnormal. An aggregate index that combined N-acerylaspartate/creatine (Cr), choline/Cr, and marker peak/Cr ratios resulted in mean scores for patients and control subjects of 4.4 ± 1.5 (standard deviation [SD]) and 2.5 ± 0.4, respectively (P = .001). Eight of 11 patients (73{\%}) had abnormal MR images versus four of 11 control subjects. Thirteen of 15 patient spectra (87{\%}) were abnormal (>2 SDs from the mean of the control subjects), while only one of 10 control spectra was abnormal. These initial results indicate that proton MR spectroscopy is a potentially useful modality for detecting HIV involvement in the central nervous system.",
keywords = "Acquired immunodeficiency syndrome (AIDS), 10.2068, Brain, infection, 10.2068, Brain, MR, 10.1214, Magnetic resonance (MR), spectroscopy, 10.12145",
author = "Jarvik, {Jeffrey G.} and Lenkinski, {Robert E.} and Grossman, {Robert I.} and Gomori, {John M.} and Schnall, {Mitchell D.} and Ian Frank",
year = "1993",
month = "3",
language = "English (US)",
volume = "186",
pages = "739--744",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - Proton MR spectroscopy of HIV-infected patients

T2 - Characterization of abnormalities with imaging and clinical correlation

AU - Jarvik, Jeffrey G.

AU - Lenkinski, Robert E.

AU - Grossman, Robert I.

AU - Gomori, John M.

AU - Schnall, Mitchell D.

AU - Frank, Ian

PY - 1993/3

Y1 - 1993/3

N2 - The purpose of this study was to characterize the proton magnetic resonance (MR) spectroscopic findings in the brains of patients infected with human immunodeficiency virus (HIV). Peak areas were used to calculate metabolite ratios. Spectra were analyzed by blinded readers who calculated areas under metabolite peaks. MR images were evaluated by blinded readers, with both white and gray matter being rated as normal or abnormal. An aggregate index that combined N-acerylaspartate/creatine (Cr), choline/Cr, and marker peak/Cr ratios resulted in mean scores for patients and control subjects of 4.4 ± 1.5 (standard deviation [SD]) and 2.5 ± 0.4, respectively (P = .001). Eight of 11 patients (73%) had abnormal MR images versus four of 11 control subjects. Thirteen of 15 patient spectra (87%) were abnormal (>2 SDs from the mean of the control subjects), while only one of 10 control spectra was abnormal. These initial results indicate that proton MR spectroscopy is a potentially useful modality for detecting HIV involvement in the central nervous system.

AB - The purpose of this study was to characterize the proton magnetic resonance (MR) spectroscopic findings in the brains of patients infected with human immunodeficiency virus (HIV). Peak areas were used to calculate metabolite ratios. Spectra were analyzed by blinded readers who calculated areas under metabolite peaks. MR images were evaluated by blinded readers, with both white and gray matter being rated as normal or abnormal. An aggregate index that combined N-acerylaspartate/creatine (Cr), choline/Cr, and marker peak/Cr ratios resulted in mean scores for patients and control subjects of 4.4 ± 1.5 (standard deviation [SD]) and 2.5 ± 0.4, respectively (P = .001). Eight of 11 patients (73%) had abnormal MR images versus four of 11 control subjects. Thirteen of 15 patient spectra (87%) were abnormal (>2 SDs from the mean of the control subjects), while only one of 10 control spectra was abnormal. These initial results indicate that proton MR spectroscopy is a potentially useful modality for detecting HIV involvement in the central nervous system.

KW - Acquired immunodeficiency syndrome (AIDS), 10.2068

KW - Brain, infection, 10.2068

KW - Brain, MR, 10.1214

KW - Magnetic resonance (MR), spectroscopy, 10.12145

UR - http://www.scopus.com/inward/record.url?scp=0027397458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027397458&partnerID=8YFLogxK

M3 - Article

VL - 186

SP - 739

EP - 744

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 3

ER -